Labshake search
Citations for Shenandoah Biotechnology :
1 - 22 of 22 citations for GRO beta CXCL2 Human since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... human EGF (20ng/mL; Shenandoah Biotech), human FGF-basic-154 (20ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... human EGF (20 ng/ml) (Shenandoah biotech), and human FGF (20 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... human-EGF (20 ng/mL; Shenandoah Biotech), human PDGF-AB (20 ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... human-EGF (20 ng/mL; Shenandoah Biotech), human PDGF-AB (20 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... and human FGF (20 ng/ml) (Shenandoah biotech). HEK293T and HEK293-FT cells were maintained in DMEM supplemented with 10% FBS,1 mM sodium pyruvate (Sigma) ...
-
bioRxiv - Cancer Biology 2020Quote: ... human-basic FGF (20 ng/mL; Shenandoah Biotech), human-EGF (20 ng/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... human PDGF-AB (20 ng/mL; Shenandoah Biotech) and heparin (10 ng/mL) ...
-
bioRxiv - Cancer Biology 2023Quote: ... human FGF-basic-154 (20ng/mL; Shenandoah Biotech), and Heparin solution 0.2% (2ug/mL final concentration ...
-
bioRxiv - Cancer Biology 2023Quote: ... human PDGF-AB (20 ng/mL; Shenandoah Biotech), B27(-A ...
-
bioRxiv - Cancer Biology 2023Quote: ... human-basic FGF (20 ng/mL; Shenandoah Biotech), human-EGF (20 ng/mL ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were treated with recombinant human GDNF (Shenandoah Biotechnology) and human GFRα1 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... human FGF (20 ng/ml, Shenandoah Biotechnology, 100-146), human EGF (20 ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... human EGF (20 ng/ml, Shenandoah Biotechnology, 100-26), human PDGF-AA (20 ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... human PDGF-AA (20 ng/ml, Shenandoah Biotechnology, 100-16), human PDGF-BB (20 ng/ml ...
-
bioRxiv - Cancer Biology 2024Quote: ... human PDGF-BB (20 ng/ml, 100-18, Shenandoah Biotechnology) and heparin (10 ng/ml ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20ng/ml Human-PDGF-BB (all Shenandoah Biotech, Warwick, PA, USA) and 2µg/ml Heparin Solution (0.2% ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... and human EGF and FGF-154 from Shenandoah Biotechnology (Warwick, PA). The IDH1 mutant cell line was named 905 and will be referred to as IDH1 mutant or R132H IDH1 mutant ...
-
bioRxiv - Cancer Biology 2021Quote: ... human growth factors (EGF, FGF, PDGF-AA, PDGF-BB [Shenandoah Biotechnology]) and heparin (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20ng/ml Human-PDGF-BB (all Shenandoah Biotech, Warwick, PA, USA) and 2µg/ml Heparin Solution (0.2% ...
-
bioRxiv - Microbiology 2022Quote: ... the media contained 50 ng/mL of recombinant human IL-4 (Shenandoah Biotechnology). Prior to imaging ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were washed twice and supplemented either with no cytokines or with human (h) IL-2 (200 ng/ml) and mouse (m) mIL-12 (10 ng/ml) from Shenandoah Biotechnology alone or in combination every three days.
-
bioRxiv - Biochemistry 2022Quote: ... TF-1 cells were also supplemented with the 2 ng/ml Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) (Shenandoah Biotechnology, 100-08). Cells were incubated in a humidified incubator at 37°C with 5% CO2.